GHRP-2: Research, Dosing, and Where to Buy in 2026
A research-first profile for GHRP-2 (growth hormone releasing peptide 2), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
GHRP-2 is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 1 transcript dosing protocol for GHRP-2, each linked to its source.
- Also indexed as growth hormone releasing peptide 2.
- 1 aggregated dosing-protocol mention from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is GHRP-2?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
GHRP-2 Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| TPC (Alex Kikel) | GROWTH HORMONE PEPTIDES (SEMINAR & PROTOCOLS) | 00:22:32 | Speaker 1 reported typical range about 100 mcg up to 1 mg, with possible multiple daily dosing but increased fluid retention at high doses. | anecdotal |
Where to Buy GHRP-2 in 2026
No tracked vendor recommendations for GHRP-2 yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about GHRP-2. Each line links to the original source.
- "Similar to what has been reported for ghrelin administration, our subjects ate 35.9 +/- 10.9% more when infused with GHRP-2 vs." · Laferrère B et al, 2005 PubMed
- "In vitro, ipamorelin released GH from primary rat pituitary cells with a potency and efficacy similar to GHRP-6 (ECs) = 1.3+/-0.4nmol/l and Emax = 85+/-5% vs 2.2+/-0.3nmol/l and 100%)." · Raun K et al, 1998 PubMed
Research and Studies
8 PubMed-indexed papers reference GHRP-2. Top 8 shown.
Legal Status
GHRP-2 is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is GHRP-2 FDA-approved?
GHRP-2 is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for GHRP-2?
This page aggregates 1 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.
How much research has been published on GHRP-2?
8 PubMed-indexed paper(s) reference GHRP-2 in our current research feed. See the Research and Studies section above for citations.